Pharmaceutical

Intercept’s liver disease drug Ocaliva faces FDA approv...

An FDA AdCom in September recommended against full approval for Ocaliva by a 13-...

MSD mulls 2025/26 launch for RSV vaccine after Phase II...

A Phase IIb/III trial with infants entering their first respiratory syncytial vi...

Avadel wins FDA approval for narcolepsy drug Lumryz in ...

The expanded approval intensifies the rivalry with Jazz Pharmaceuticals, which h...

mRNA licensing agreements surge 800% amid GSK lawsuits

An 800% increase in licensing deal values indicates growing confidence in mRNA t...

Radiopharm and AtomVie partner on radioantibody develop...

Radiopharm Theranostics (RAD) and AtomVie have announced a partnership for the d...

Sage lays off 55% of R&D workforce and refocuses pipeline

Strategic restructuring will support the ongoing launch of the oral postpartum d...

Bavarian Nordic’s mpox vaccine equally effective in tee...

Bavarian Nordic’s MVA-BN vaccine showed equivalent antibody response and safety ...

Fresenius Kabi and Cellular Origins agree CGT manufactu...

Fresenius Kabi and Cellular Origins have announced a partnership to advance cell...

Glaukos eyes FDA approval for ocular therapy after Phas...

The company’s keratoconus medication, Epioxa, was effective in a Phase III trial...

Health Canada approves Acadia’s DAYBUE for Rett syndrome

Acadia Pharmaceuticals has received marketing authorisation from Health Canada f...

Lexicon partners Viatris for global expansion of sotagl...

Lexicon Pharmaceuticals has entered a licensing agreement with Viatris to commer...

J&J trims neuroscience pipeline – seltorexant in Alzhei...

J&J has cut two Phase II programmes and one Phase I asset in its neuroscience po...

Eli Lilly will ‘build new way of doing science’ in UK a...

Lilly’s senior VP of information and R&D IT Ramesh Durvasula said Lilly will use...

bit.bio defends European patent for ‘novel’ opti-ox tec...

bit.bio’s method for pluripotent stem cell (PSC) programming, opti-ox, was deeme...

Almirall completes EU regulatory procedure for antifung...

Almirall has completed the decentralised regulatory procedure in Europe for efin...

Parenteral Solutions in Contract Manufacturing for the ...

Discover the leading Parenteral Solutions in Pharmaceutical Contract Manufacturi...